on adolescents with poorly controlled T1D demonstrated a significant improvement in Hba1c (9.6 to 8.7%) and IS among those receiving Metformin for 3 months, without any effect on insulin requirement, body weight, waist and hip circumferences or blood lipid concentrations (14). This evidence concerns the gene INS and type 1 diabetes mellitus.